Renal disease is a major complication in diabetes and one of the major causes of end-stage renal failure. Clinical Approach to Renal Diseases in Diabetes highlights the development of diabetes mellitus, renal involvement and other comorbid conditions along with the latest therapeutic regimens. This book is comprised of 12 chapters, which discuss a range of topics in detail including diabetic kidney disease, risk factors for diabetic nephropathy, pathophysiology of diabetic nephropathy, microalbuminuria in diabetic nephropathy, diabetic nephropathy treatment, hyperglycaemia control, treatment of hypertension, proteinuria therapy, diabetic nephropathy and cardiovascular morbidity. The preventability of diabetic nephropathy is debated, including the prevention of microalbuminuria through renin angiotensin system, inhibitor therapy and the role of biomarkers in diabetic nephropathy. Clinical Approach to Renal Diseases in Diabetes covers all aspects of renal involvement in diabetes, providing a useful resource to general practitioners, urologists, nephrologists and diabetologists. Key Points Comprehensive guide covers all elements of renal involvement in diabetesIncludes debate on the preventability of diabetic nephropathy45 full colour illustrations and tables

This book focuses on the renal complications associated with diabetes. The first chapter provides an overview of the current scenario with respect to diabetes in the world and India in particular, factors contributing to the development of diabetes as well as measures to prevent it. The subsequent chapters deal with diabetic kidney disease (DKD), risk factors and pathophysiology of DKD. The use of microalbuminuria as a biomarker to monitor the development and progression of DKD as well as the possibility of prevention in early stages are described. Chapters 7 to 9 describe therapeutic measures including hyperglycemia control, hypertension and proteinuria therapy as well as diet control (protein and salt restriction), cessation of smoking, weight reduction and dyslipidemia therapy. Newer therapeutic approaches are also described. The last three chapters describe other clinical manifestations of diabetic kidney disease, cardiovascular morbidity and end stage renal disease (ESRD) and their management.

T Dhinakaran, Madurai Kidney Centre and Transplantation Research Institute, Madurai, Tamil Nadu, India; Southern Chapter Indian Society of Nephrology, India; Nephrology Association of Tamilnadu and Puducherry, Tamil Nadu, India